Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-23-040524
Filing Date
2023-11-13
Accepted
2023-11-13 16:19:05
Documents
5
Effectiveness Date
2023-11-13

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 83209
2 ex5-1.htm EX-5.1 14431
3 ex23-1.htm EX-23.1 3377
4 ex107-1.htm EX-FILING FEES 20019
5 ex5-1_001.jpg GRAPHIC 2389
  Complete submission text file 0001493152-23-040524.txt   125557
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275505 | Film No.: 231399055
SIC: 2836 Biological Products, (No Diagnostic Substances)